“you will find a value in the undervalued” –

New York, NY (Vocus) 17 March 2010

PINKSHEETS

negotiated Guided Therapeutics, Inc. (GT) announced on 02.23.2010, publication of results next crucial U.S. Food and Drug Administration (FDA) for the pivotal clinical Light Touch (TM) non-invasive cervical cancer detection. TooNiceStocks looks bullish rally occurring this revolutionary system cancer screening has five family physicians plan to be submitted to the American Society for Colposcopy and Cervical Pathology Biennial Meeting, from 24 March runs – 27, 2010 Las Vegas, NV.

techniques: Guided Therapeutics, Inc. is a real potential for discussion. If we look back at the table in November 2009, an outbreak took place on 11.23.2009 up and GT reached a high of 52 weeks 0.70. Perhaps a simple GT twice as high? With the data that the FDA threatens next week and a small float of shares to the public, this could very well be the case. Looking back 30 days GT climbed comfortably in a $ 0.80 intraday high of 0.10 recently. GT is trading above its moving average 13 days, which is a sign of an upward trend. In addition, there are the more important because this indication is increasing the moving average, and suggests that there is interest in buying this stock. WG closed above the trigger of the Parabolic SAR, and is currently recording a bullish signal.

Due Diligence: Guided Therapeutics, Inc. currently serves 16 U.S. patents (You can read all 16 patents in detail by consulting the full report of the due diligence www.TooNiceStocks.com). If the results of the FDA-approval study data from clinical trials are impressive, we are going GT leaps and bounds. If the group of five leading doctors agree that Light Touch (TM) is sufficient, then maybe they have a breakthrough. Cervical cancer market is huge and shows no signs of weakening in the cancer market. Marketresearch.com states that â?? Projections show significant growth by 2016, global data estimated the global market for cervical cancer should be valued at 0.8 billion dollars in 2009. It should be 0.1 billion in 2016, an average annual growth rate (CAGR) of 11.9% between 2009 and 2016.â? This growth is mainly due to increased competition between the existing therapies for cervical cancer, vaccines and detection systems on the market. On the financing side, the National Cancer Institute has 0.5 million GRT in a non-invasive cervical cancer detection devices market. GT has also recently received a commitment of new funds Konica Minolta Opto, Inc. in the expansion of product lines for the detection of cancer should be a commitment worth $ 0.59 over 12 months. More important in this new release, BusinessWire, a brand L. Faupel, Ph.D., president and CEO of GT said?? We are pleased that the authors of the presentation, all of whom are leaders in the women? S health care, support and technology agreed Light touch, talk about their potential for early detection of cervical cancer cancer.â ????

Digging Deeper

: TooNiceStocks.com spoke with a high level professionals in the biotech industry cervical cancer. This suggests that a professional?? One of their patents, which describes their technology is different test of the failure of the light-based approaches for non-invasive blood sugar. Their approach is the image of the tissue to search for morphological and biochemical changes in the underlying tissue. The failure of the glucose test is to calibrate the accuracy of test results and a path to the system. In this case they are looking for differences in tissue-based background lighting (fluorescent and reflected light). You are not looking for a specific value and normal tissue may act as a means of calibration or background signal. I think Light Touch? ¢ system has real potential, however, clinical studies will be the key to their success.â?? If the results are overwhelmingly strong, we will retest the 52 week high and more willing to create new highs, as we did not see Guided Therapeutics, Inc. today traded at these levels again. So many uncertainties still one is sure that the rally started on GT.

? Search for value in the Undervalued.â? â??

Toonicestocks.com (â?? ????) website was not compensated, but they have made their own independent research on Guided Therapeutics, Inc. The site is not investment advice or a registered investment advisor or broker and does not say or think that clients should sell securities or to buy your own. You understand and acknowledge that there are a high level of risk associated with trading of securities. The website, authors, publishers, and all affiliates assume no responsibility for the site or liability for your trading and investment results. Factual statements on the website or in its publications, are made from the date indicated and may change without notice. Do not assume that the methods, techniques, or indicators presented in these products is not profitable or result in losses. The examples presented at Toonicestock.comâ?? S Web site are provided for educational purposes only. These settings are not all requests for purchase or sale. You should therefore not only to make the information on each investment. Instead, you must use the information as a starting point for further independent research, to help you make your own opinion regarding investments. You should always check with your authorized financial advisor and tax advisor to determine the suitability of an investment. Please read the full disclaimer on the site.


P

###

clear = “all”
the treatment of cervical cancer